--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Deutsches Ärzteblatt" developer_entity: "Deutscher Aerzte-Verlag GmbH" bundle_id: "de.aerzteblatt.tablet" app_store_id: "1094745710" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: true market_region: "US" platforms: "iOS" app_last_updated: "2026-06-03" report_date: "2026-08-05" last_verified: "2026-08-05T00:00:00.000Z" report_version: "3.16.0" total_reviews: 0 confidence: "low" confidence_score: 0.05 data_age_days: 62 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "freemium", "mobile app", "app review", "app analysis", "physicians", "medical", "students"] canonical_url: "https://marlvel.ai/apps/deutsches-arzteblatt" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Deutsches Ärzteblatt Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Freemium > **TL;DR:** Deutsches Ärzteblatt is a medical app by Deutscher Aerzte-Verlag GmbH, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Deutsches Ärzteblatt is a medical app by Deutscher Aerzte-Verlag GmbH. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | Deutscher Aerzte-Verlag GmbH | | **Pricing** | Freemium | | **Platforms** | iOS | | **Confidence** | Low (0.05/1.0) | | **Data Age** | 62d | ## Metadata & Market Performance - **Publisher:** Deutscher Aerzte-Verlag GmbH - **Category:** Medical - **Target Audience:** Physicians and medical students requiring access to professional journals, news, and certified medical education credits. - **Platforms:** iOS - **Version Reviewed:** 3.16.0 - **Report Date:** 2026-08-05 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 1094745710 - **Bundle ID:** de.aerzteblatt.tablet - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-05 ## Executive Snapshot **What it is:** Deutsches Ärzteblatt is a professional medical journal and CME certification app for physicians and students on iOS. **Why users hire it:** The app removes the friction of physical journal distribution and external CME portals by centralizing professional reading and certification in one verified environment. ## App DNA (Features & Intent) - **[Differentiator] CME Certification:** Integrated platform for physicians to complete certified continuing medical education credits directly within the app, reinforcing its role as a primary professional tool. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Digital ePaper Reader:** Displays the full printed edition of Deutsches Ärzteblatt and associated publications, maintaining subscriber loyalty and reducing distribution costs. * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Standard] Offline Article Access:** Downloads magazine content for reading without an active internet connection, ensuring consistent consumption during clinical downtime. * *User Intent:* Users want uninterrupted access without internet dependency. ## Market Position {#market-position} Deutsches Ärzteblatt maintains a niche position in the Medical category, serving as the primary digital touchpoint for its professional subscriber base. The lack of recent feature updates suggests a focus on stability over market share expansion. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free access for registered medical professionals, Subscription-based access for ePaper and CME participation - **Analysis:** The model uses professional registration (EFN or subscription number) as a gate to verify the target audience and manage access to restricted medical content. ## SWOT Analysis {#swot} **Core Strengths:** - Professional registration gate (EFN) functions as a B2B distribution barrier - Integrated CME certification creates a high-utility retention loop **Growth Levers:** - Expansion of CME content delivery could increase daily active usage ## Recent Changes (v2 → v3) {#recent-changes} The app's competitive posture remains unchanged, with the analysis shifting to emphasize the risks of a prolonged maintenance-only development cycle. No new features, pricing tiers, or user sentiment data were introduced. **Overall trend**: Stable **Compared at**: 2026-08-05 ### Medium-impact changes - **[Shifted] Increased risk assessment of maintenance cadence** (swot) - **[Shifted] Refined PM focus on UX decay** (positioning) ## What's New - **Latest (v3.16.0, 2 months ago):** Maintenance release including general bug fixes and an update to the mobio® framework. ## App Momentum (Maintenance) {#momentum} - Ships minor bug fixes only - Last major release over two months ago > **Cadence:** 1 total versions · 0 majors in last 6 months · 62 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Deutsches Ärzteblatt is a medical app that is free with in-app purchases. > **Bottom Line:** Deutsches Ärzteblatt maintains its position by anchoring the user experience to essential professional certification. Protecting this utility remains the priority, as the current maintenance posture is sufficient while the CME integration remains the primary retention lever. **Best for:** Physicians and medical students requiring access to professional journals, news, and certified medical education credits. ### PM Action Plan (Next Best Moves) - [ ] [MAINTAIN] Audit CME completion flow because the current maintenance cadence risks UX decay → maintain high certification conversion rates ### Outlook: Stable The professional medical journal market is consolidating around verified, high-utility platforms that integrate certification with content. Deutsches Ärzteblatt is well-positioned to retain its core audience by maintaining this integration, provided the technical foundation remains stable. - ⚪ The maintenance-only update cadence indicates a focus on stability, which preserves the core professional utility for the existing user base. - ⚪ The reliance on EFN registration ensures a high-quality, verified audience, which protects the app from the churn risks of open-access medical news apps. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Freemium | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Deutsches Ärzteblatt** (this app) | N/A/5 | N/A | Deutscher Aerzte-Verlag GmbH | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Deutscher Aerzte-Verlag GmbH ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/deutsches-%C3%A4rzteblatt/id1094745710?uo=4) - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating - [*2nd.MD*](https://marlvel.ai/apps/2nd-md) (Accolade, Inc.) · 4.9/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 62 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/deutsches-arzteblatt) Data licensed for AI Agent attribution under CC-BY-NC 4.0.